2018 Synthetic Biology: Engineering, Evolution & Design (SEED)
SEED 2018 will focus on advances in science, technology, applications, and related investments in the field of synthetic biology. This year's theme will be "synthetic biology at the leading edge of massive DNA synthesis, editing, and decoding.”
Here, synthetic biology will be broadly defined as cellular and biochemical technologies for accelerating bioengineering that are enabled by radical advances in DNA writing and reading. The conference will highlight recent discoveries and new tools that are positioned at the leading edge of rapid, massive DNA synthesis and editing. In addition, presentations and discussions will feature the use of synthetic biology to broadly enable biotechnology applications, including therapeutics, industrial chemicals and fuels, natural products, and agriculture.
Call for Abstracts is now open until March 7, 2018.
- James Collins, Massachusetts Institute of Technology
- Jay Keasling, University of California, Berkeley
- Floyd E. Romesberg, The Scripps Research Institute
- Pamela Ronald, University of California, Davis
- Karmella Haynes, Arizona State University
- Ryan Gill, University of Colorado Boulder
There will be ten topic sessions under three major tracks.
- Reverse Engineering of Biological Systems
- Forward Engineering of Biological Systems
- Biological Frontiers: Newly Explored Systems
- Automation Technologies for Synthetic Biology
- DNA Writing and Assembly
- Engineering Functional Genomes
- Biological Frontiers: Newly Enabled Applications
- Biology-Inspired Materials
- Industrial Biotechnology
- Human Health
James J. Collins is the Termeer Professor of Medical Engineering & Science and Professor of Biological Engineering at MIT. His research group focuses on using network biology approaches to study antibiotic action, bacterial defense mechanisms, and the emergence of resistance. His patented technologies have been licensed by over 25 companies.Read more